In the context of drug resistance and breast tumor recurrence, Smoothened and Gli1 were reported to be significantly upregulated in tamoxifen-resistant derivative of otherwise tamoxifen-sensitive MCF-7 and T47D breast cancer cells [128]. This evidence concerns the gene GLI1 and breast carcinoma.